Alkermes Plc
NASDAQ:ALKS
Alkermes Plc
NASDAQ:ALKS
Price:
23.86 USD
-0.62%
Market Closed
Updated:
May 3, 2024
Alkermes Plc
Net Income (Common)
|
Alkermes Plc
Net Income (Common) Peer Comparison
Comparables:
AMRN
PRTA
M
MURA
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Alkermes Plc
NASDAQ:ALKS
|
Net Income (Common)
$355.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
33%
|
|
|
Amarin Corporation PLC
NASDAQ:AMRN
|
Net Income (Common)
-$59.1m
|
CAGR 3-Years
-49%
|
CAGR 5-Years
13%
|
CAGR 10-Years
10%
|
|
|
Prothena Corporation PLC
NASDAQ:PRTA
|
Net Income (Common)
-$147m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-14%
|
|
M
|
Mural Oncology PLC
NASDAQ:MURA
|
Net Income (Common)
-$207.4m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Alkermes Plc's Net Income (Common)?
Net Income (Common)
355.8m
USD
355.8m
USD
Based on the financial report for Dec 31, 2023, Alkermes Plc's Net Income (Common) amounts to 355.8m USD.
What is Alkermes Plc's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
33%
33%
You don't have any saved screeners yet
